| scholarly article | Q13442814 |
| P2093 | author name string | M. Burger | |
| Z. G. Oades | |||
| H. Takamori | |||
| I. U. Schraufstatter | |||
| O. C. Hoch | |||
| P433 | issue | 1 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| cell line | Q21014462 | ||
| cancer cell line | Q23058136 | ||
| P304 | page(s) | 52–56 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Pancreas | Q15762014 |
| P1476 | title | Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1 | |
| P478 | volume | 21 |
| Q39557213 | A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. |
| Q37709556 | Anti-inflammatory agents as cancer therapeutics |
| Q38909630 | Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists |
| Q95840394 | BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer |
| Q40724369 | CXC and CC chemokines as angiogenic modulators in nonhaematological tumors. |
| Q30432791 | CXC chemokines in cancer angiogenesis and metastases |
| Q58761517 | CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer |
| Q36723785 | CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growth |
| Q30358993 | CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer. |
| Q35078196 | CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling |
| Q27021588 | CXCR2: a target for pancreatic cancer treatment? |
| Q64889128 | Cancer-Associated Fibroblasts Enhance Survival and Progression of the Aggressive Pancreatic Tumor Via FGF-2 and CXCL8. |
| Q35031912 | Chemokine biology in cancer. |
| Q26866236 | Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges |
| Q28200068 | Chemokines and disease |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
| Q34119204 | Chemokines in cancer |
| Q37608615 | Chemokines in tumor-associated angiogenesis. |
| Q35989733 | Computational Reconstruction of NFκB Pathway Interaction Mechanisms during Prostate Cancer |
| Q40705828 | Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation |
| Q36659818 | Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values |
| Q42718218 | Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer |
| Q47271643 | Differences in Stem Cell Processing Lead to Distinct Secretomes Secretion-Implications for Differential Results of Previous Clinical Trials of Stem Cell Therapy for Myocardial Infarction. |
| Q37149860 | Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1. |
| Q36510801 | EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway |
| Q28208400 | Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma |
| Q35543779 | Fine Tuning the Transcriptional Regulation of the CXCL1 Chemokine |
| Q44542020 | Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer--under-analysis of cumulative survival curve |
| Q86560479 | Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma |
| Q35115253 | Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer |
| Q34646491 | Inflammation and the development of pancreatic cancer |
| Q48146142 | Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers |
| Q39481178 | Interleukin-8 derived from local tissue-resident stromal cells promotes tumor cell invasion |
| Q34091347 | Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer |
| Q42818551 | KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway |
| Q90665164 | Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes |
| Q36429600 | Mitogenic effects of interleukin-8/CXCL8 on cancer cells |
| Q39816229 | Overexpression of VCC-1 gene in human hepatocellular carcinoma cells promotes cell proliferation and invasion |
| Q53245654 | Overexpression of interleukins IL-17 and IL-8 with poor prognosis in colorectal cancer induces metastasis. |
| Q30332571 | Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. |
| Q24805285 | Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy |
| Q55497094 | Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player? |
| Q35770942 | Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis. |
| Q39321350 | Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases |
| Q39456823 | SASP: Tumor Suppressor or Promoter? Yes! |
| Q39636176 | Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications |
| Q36843035 | Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis. |
| Q36150219 | Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment |
| Q39018419 | The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence |
| Q88718629 | The Role of TRP Channels in the Metastatic Cascade |
| Q90177345 | The biological mechanism involved in anticancer properties of amniotic membrane |
| Q35820525 | The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival |
| Q38023245 | The role of CXC chemokines and their receptors in the progression and treatment of tumors |
| Q38211076 | The role of inflammation in pancreatic cancer |
| Q38211082 | The role of inflammation in sarcoma |
| Q37322616 | Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin |
| Q37788679 | Tumor Infiltrating Regulatory T Cells: Tractable Targets for Immunotherapy |
| Q52618088 | Tumour-derived GM-CSF promotes granulocyte immunosuppression in mesothelioma patients. |
| Q27851827 | p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. |
Search more.